OncLive® Events Scientific Interchange and Workshop Series | OncLive

OncLive® Events Scientific Interchange and Workshop Series

OncLive® Events conducts independent live and virtual focus groups on a high-interest disease state with the goal to gain unbiased insights on the disease state, ongoing clinical trials, and market trends, including how specific drug candidates may fit into the treatment landscape. OncLive will independently recruit 8-12 academic or community advisors, and develop the full agenda and program content. Your team can silently observe these important discussions and will receive our executive summary post program.

Contact Your OncLive® Events Representative Today!

Rita Piotti
(215) 800-2178
rpiotti@onclive.com

Elisha Garcia
(609) 613-8698
egarcia@onclive.com

Chelsea DeLisa
(609) 529-9016
cdelisa@onclive.com

Upcoming Programs

NameDateLocationProgram Objective
OncLive® Scientific Interchange and Workshop: Advanced, HER2+ Expressing Breast CancerOctoberVirtual ProgramView Program Objectives PDF
Updates in Relapsed/Refractory Metastatic Renal Cell CarcinomaOctoberVirtual ProgramView Program Objectives PDF
Current and Emerging Treatment for the Management of Tenosynovial Giant Cell TumorsOngoing Summer SeriesVirtual ProgramView Program Objectives PDF
Bruton Tyrosine Kinase Inhibitors in B-Cell LymphomasOngoing Summer SeriesVirtual ProgramView Program Objectives PDF

Future Programs

  • OncLive® Metastatic NSCLC Workshop: Applying New Data to Patient Care
  • Updates in the Treatment of Gynecological Malignancies: Ovarian, Cervical and Endometrial Cancers
  • Title to Be Determined: Advances in Renal Cell Carcinoma
  • Optimizing the Use of Molecular Testing in Solid Tumors
  • Title to Be Determined: Focus on Lymphomas
  • The Role of FLT3 Inhibition in AML: Emerging Strategies and Opportunities
  • And More Topics to Be Announced!

Past 2020 Programs & Topics

NameDateLocation
ASCO GI: Current and Emerging Treatments For Neuroendocrine Tumors: An OncLive® Scientific Interchange and WorkshopJanuarySan Francisco, CA
ASCO GI: HER2+ Gastrointestinal Malignancies: An OncLive Scientific Interchange and WorkshopJanuarySan Francisco, CA
Advanced HER2 Expressing Breast Cancer WorkshopJanuaryMiami, FL
Treatment of Relapsed Refractory Diffuse Large B-Cell LymphomaFebruaryMiami, FL
OncLive® Workshop Discussing Community-Based Management of Chronic Lymphocytic Leukemia (CLL)FebruaryMiami, FL
A Consultative Workshop on the Treatment of Hodgkin Lymphoma and Peripheral T-Cell LymphomaMarchKansas City, MO
Current and Emerging Concepts in Relapsed Refractory Diffuse Large B-cell LymphomaMarchVirtual
Toxicity Management in Multiple MyelomaMarchMiami, FL
HER2+ Gastrointestinal MalignanciesMarchOxon, MD
Later Line Therapy for Advanced, HER2-Expressing Breast CancerMarchVirtual
PARP Inhibition in Ovarian Cancer: Considerations for Maintenance Therapy: An OncLive Scientific Interchange and WorkshopMarchVirtual
CSCC: Advancements in the Treatment of Keratinocyte CarcinomasJuneVirtual ProgramView Program Objectives PDF
ASCO: Non-Small Cell Lung Cancer WorkshopJuneVirtual Program

Coming Soon

PARP Inhibition in Ovarian Cancer: Considerations for Maintenance TherapyJuneVirtual ProgramView Program Objectives PDF
Advancements in the Treatment of Keratinocyte CarcinomasJuneVirtual Program

Coming Soon

Antibody Drug Conjugates in HER2+ Breast CancerJulyVirtual ProgramView Program Objectives PDF
BTK Inhibitors in B-Cell Malignancies OncLive WorkshopJuly 15Virtual WorkshopView Program Objectives PDF
Current and Future Trends in NETJuly 16Virtual Webcast

Coming Soon

Current and Emerging Treatments in Follicular LymphomaJuly 29Virtual WorkshopView Program Objectives PDF
The Role of Chemotherapy and Novel Combinations in Triple Negative Breast CancerJuly 29Virtual ProgramView Program Objectives PDF
Updates and New Targets in NSCLCAugust 5Virtual MeetingView Program Objectives PDF
Updates in Metastatic Renal Cell Carcinoma: An OncLive Scientific Interchange and WorkshopAugust 6Virtual MeetingView Program Objectives PDF
Current and Emerging Treatments for the Management of Tenosynovial Giant Cell Tumors (TCGT)August 12Virtual WebcastView Program Objectives PDF
x